Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12® rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study - Malinin, Alex; Pokov, Alex; Spergling, Malcolm; Defranco, Anthony; Schwartz, Kenneth; Schwartz, Dianne; Mahmud, Ehtisham; Atar, Dan; Serebruany, Victor (Thrombosis research, 2007)
Keywords: Adenosine Diphosphate - pharmacology; Adult; Aged; Alprostadil - pharmacology; Biological and medical sciences; Blood and lymphatic vessels; Blood coagulation. Blood cells; Blood Platelets - metabolism; Blood. Blood coagulation. Reticuloendothelial system; Cardiology. Vascular system; Coronary Disease - complications; Coronary Disease - metabolism; Coronary Disease - therapy; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous; Female; Fundamental and applied biological sciences. Psychology; Humans; Male; Medical sciences; Middle Aged; Molecular and cellular biology; Monitoring, Physiologic - instrumentation; Monitoring, Physiologic - methods; Pharmacology. Drug treatments; Platelet; Platelet Aggregation - drug effects; Platelet Aggregation Inhibitors - administration & dosage; Platelet Function Tests - instrumentation; Platelet Function Tests - methods; Prospective Studies; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1; Stents; Thrombosis - etiology; Thrombosis - metabolism; Thrombosis - prevention & control; Ticlopidine - administration & dosage; Ticlopidine - analogs & derivatives; Prostaglandin-endoperoxide synthase; Calcium; Cardiovascular disease; Prostaglandin E1; Acetylsalicylic acid; Inorganic element; ADP; Stent; Aggregation; Vascular disease; Salicylates; Prospective study; Monitoring; Human; Enzyme; Enzyme inhibitor; Coronary heart disease; Thrombosis; Antiplatelet agent; Non steroidal antiinflammatory agent; Platelet; Analgesic; Treatment; Platelet function analyzer; Risk factor; Platelet function; Antipyretic; Clopidogrel; Oxidoreductases; Thienopyridine derivative; Platelets